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Dendritic Cell Subtypes from Lymph Nodes and Blood Show
Contrasted Gene Expression Programs upon Bluetongue Virus
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Human and animal hemorrhagic viruses initially target dendritic cells (DCs). It has been proposed, but not documented,
that both plasmacytoid DCs (pDCs) and conventional DCs (cDCs) may participate in the cytokine storm encountered in
these infections. In order to evaluate the contribution of DCs in hemorrhagic virus pathogenesis, we performed a genome-
wide expression analysis during infection by Bluetongue virus (BTV), a double-stranded RNA virus that induces hemor-
rhagic fever in sheep and initially infects cDCs. Both pDCs and cDCs accumulated in regional lymph nodes and spleen dur-
ing BTV infection. The gene response profiles were performed at the onset of the disease and markedly differed with the
DC subtypes and their lymphoid organ location. An integrative knowledge-based analysis revealed that blood pDCs dis-
played a gene signature related to activation of systemic inflammation and permeability of vasculature. In contrast, the
gene profile of pDCs and cDCs in lymph nodes was oriented to inhibition of inflammation, whereas spleen cDCs did not
show a clear functional orientation. These analyses indicate that tissue location and DC subtype affect the functional gene
expression program induced by BTV and suggest the involvement of blood pDCs in the inflammation and plasma leakage/
hemorrhage during BTV infection in the real natural host of the virus. These findings open the avenue to target DCs for
therapeutic interventions in viral hemorrhagic diseases.
Bluetongue virus (BTV) is a double-stranded RNA virus of theReoviridae family that is transmitted by insect vectors to ru-
minants. Whereas BTV infection has been endemic for several
centuries in Southern Africa, it recently caused major outbreaks in
several northern European countries with severe economical con-
sequences in sheep and cattle (1, 2). Bluetongue disease (BT) is
characterized by fever, vascular injury with hemorrhages, tissue
infarctions, and widespread edema, lesions that are consistent
with those of the so-called viral hemorrhagic fevers (3–6). After
inoculation in the skin, the virus migrates, associated to conven-
tional dendritic cells (cDCs), to the regional lymph node, where
initial replication occurs (7, 8). BTV is then disseminated to a
variety of tissues, and it replicates in monocytes (9), endothelial
cells (10), and / T lymphocytes (11).
In several hemorrhagic viral infections, dendritic cells (DCs)
have been proposed to be implicated in the virus dispersion
around the body as well as in the fever, the inflammatory status,
and the altered vascular functions, although in vivo evidence sup-
porting the importance of their role is lacking (12). DCs include
two major subsets, the cDCs, which are specialized in antigen
processing and presentation to T lymphocytes, and the plasmacy-
toid DCs (pDCs), which produce large amounts of type I inter-
feron (IFN) and other inflammatory cytokines upon virus infec-
tion. The cDCs are the early cell targets of BTV (8) and of other
hemorrhagic viruses (13–16). BTV replicates both in cDCs and in
pDCs and activates them in vitro (8, 17). Thus, BTV infection in
sheep appears as a pertinent infection model to study the contri-
butions of DCs in hemorrhagic fever virus pathogenesis in a nat-
ural host. Furthermore, this relatively convenient animal model
allows extraction of both pDCs and cDCs from different lymphoid
organs in order to perform analyses of gene expression during
infection. Indeed, lymphoid compartments are differentially in-
volved during BTV infection: BTV first replicates in the lymph
node that drains the inoculation site and then disseminates to
other secondary lymphoid organs via blood (18, 19). Using ge-
nome-wide expression profiling, we present evidence that BTV
infection modifies the gene expression programs in pDCs and
cDCs depending on the lymphoid organs and suggest their role in
the expression of clinical symptoms and in the control of the dis-
ease.
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MATERIALS AND METHODS
Sheep infection and sample collections. BTV-negative male lambs of
Prealpes breed (4 to 5 months old) were used in this study. Nineteen sheep
were infected subcutaneously in the shoulder area and intravenously with
1 and 5 ml, respectively, of blood from a viremic BTV8-infected animal
(8.1 106 BTV8 RNA copies/ml). This procedure was previously shown
by us to induce high viremia and clinical disease (20). Eleven sheep were
used as negative controls. Animal experimentation was performed as pre-
scribed by the guidelines of the European Community Council on Animal
Care (86/609/CEE) in the biosafety level 3 (BSL3) facilities of the
INRA-UE 1277 “Plateforme d’Infectiologie Expérimentale” in Nouzilly,
France, under the “Direction départementale de la protection des popu-
lations,” authorization number B-37-175-3. The animal experiments
were carried out under licenses issued by the Direction of the Veterinary
Services of Versailles (accreditation numbers B78-93) and of Toulouse
(311-055-524). Clinical signs and rectal temperature were recorded every
day as described in a previous study (20). BTV RNA was measured by
quantitative reverse transcription-PCR (qRT-PCR) assays of blood col-
lected in EDTA, sampled every 2 days beginning 3 days before virus inoc-
ulation until the end of the experiment (day 21). A standard plasmid curve
for quantification was obtained by dilutions of plasmid pBTVM contain-
ing the L1 gene replicon (kindly provided by E. Sellal, Laboratoire Service
International). Three control sheep were sacrificed at day 0 (D0) before
BTV8 infection. At days 2, 6, and 10 postinoculation, 3 infected sheep
were euthanized for collection of tissues. Just before these slaughters, 500
ml of blood per sheep was collected on sodium citrate. The prescapular
lymph node draining the subcutaneous inoculation site, and a slice of the
spleen were harvested and weighed. The complexity of the experiment in
a large-animal BSL3 facility, the logistics, and the high cost dictated the
relatively low number of sheep used in this study.
Cell isolation from lymph node, spleen, and blood. Lymph nodes
were cut in small pieces and treated with collagenase (2 mg/ml; Roche),
DNase (2 mg/ml; Roche), and dispase (0.5 mg/ml; Gibco-BRL) in RPMI
1640 supplemented with 10% heat-inactivated fetal calf serum (FCS) for 1
h at 37°C. The lymph node cell suspension was filtered through a 100-m
polypropylene cell strainer (Becton, Dickinson). The spleen tissue was cut
in small pieces, and the suspension was sequentially filtered through a
500-m steel strainer and a 100-m polypropylene cell strainer. The
splenic cells were further purified on a 1.076 density Percoll gradient (GE
Healthcare), following the same protocol as for sheep peripheral blood
mononuclear cells (PBMCs) (21). The total number of spleen and lymph
node cells per gram of tissue was calculated after cell counting with a
hemocytometer. Low-density (LD) lymph node, spleen, and PBMCs were
obtained by centrifugation on a 1.065 density iodixanol gradient (Op-
tiprep; Nycomed Pharma) as previously described (22). LD cells were
counted after each preparation. LD lymph node and spleen cells and LD
PBMCs were frozen in FCS containing 10% dimethyl sulfoxide (Sigma)
and stored in liquid nitrogen.
DC staining and isolation. cDCs and pDCs were stained and sorted
from LD frozen spleen, blood cells, and nodes. For the staining of spleen
and blood cDCs and pDCs, cells were reacted with anti-CD11c monoclo-
nal antibody (MAb) (2g/ml, OM1 clone, IgG1) followed by a saturating
concentration of Alexa Fluor 488-conjugated anti-mouse IgG donkey Fab
(50 g/ml). After extensive washing, cells were further incubated with 2
g/ml of anti-CD45RB (CC76 clone, IgG1), anti-B cells (DU2-104 clone,
IgM), anti-CD8 (7C2 clone, IgG2a), anti-TCR/ (CC15 clone, IgG2a),
and anti-CD11b (ILA-130 clone, IgG2a), followed by phycoerythrin- and
Alexa Fluor 647-conjugated goat anti-mouse isotype-specific antibodies
(Caltag). For the staining of lymph node cDCs and pDCs, cells were pro-
cessed as described above, except that cDCs were labeled with anti-CD1b
MAb (Th97A, IgG2a). After the final wash, cells were resuspended in
Hanks balanced salt solution (HBSS)  1% heat-inactivated FCS for cy-
tometry sorting or in phosphate-buffered saline (PBS) for fluorescence-
activated cell sorter (FACS) analysis. The pDCs and cDCs were sorted by
flow cytometry on the Imagif Cytometry platform using the analyzer-
sorter MoFlo XDP cytometer and the Summit 5.2 software (purity,
98%; Beckman Coulter). The FACS analyses of the pDC and cDC rep-
resentation in lymphoid organs were done with a FACSCalibur using the
CELLQuest software (Becton, Dickinson). The percent representation of
each DC subset in LD cells was used to calculate their number from gram
of tissue (lymph node/spleen) or from ml of blood, based on the numbers
of collected LD cells and of total cells.
RNA extraction and hybridization onmicroarrays. Total RNA from
pDCs and cDCs was extracted using the Arcturus PicoPure RNA Isolation
kit (Arcturus Life Technologies) and checked for quality with an Agilent
2100 Bioanalyzer using RNA 6000 Nano or Pico Kits (Agilent Technolo-
gies). All RNA samples had an RNA integrity number (RIN) above 8. RNA
amplification and labeling were performed using the one-color Low Input
Quick Amp Labeling kit (Agilent Technologies) according to the manu-
facturer’s recommendations. Each RNA sample (25 to 50 ng) was ampli-
fied and cyanin 3 (Cy3) labeled, and subsequently the cRNA was checked
for quality on Nanodrop and Agilent 2100 Bioanalyzer. Subsequently the
cRNA (600 ng) was fragmented and used for hybridization on custom-
designed Agilent ovine arrays (ID 29915). Our custom-designed ovine ar-
ray is based on the commercial ovine Agilent array (15,208 60mer probes;
AMADID, 1992; Agilent Technologies). About 5,000 probes of the commer-
cial ovine array were replaced, based on quality analyses made by the Sigre-
annot program from the Sigenae group (23). New probes were designed with
the e-array software from Agilent Technologies (custom AMADID, 29915).
The new probes (4,921 in total) included ovine gene sequences derived from
(i) ovine Sigenae contigs (http://www.sigenae.org/) and (ii) ovine or bovine
expressed sequence tags corresponding to genes known to be selectively ex-
pressed in human and mouse DC subsets (24). The ovine microarray has been
annotated by the Sigreannot program (23) and by blasting the ovine ex-
pressed sequence tags against bovine sequences (RefSeq Bos taurus) in order
to identify the putative bovine orthologous gene (200 nucleotides [nt] with
92% identity). After hybridization of the cRNA on the custom-designed
ovine array, the chips were washed according to the manufacturer’s protocol.
The chips were then scanned by using a G2505C scanner (Agilent Technolo-
gies) at a resolution of 5 m. Raw data were extracted using the Feature
Extraction v7.10.3.1 software (Agilent Technologies). All the protocols used
can be obtained by contacting the CRB GADIE facility (http://crb-gadie.inra
.fr/).
Microarray analyses. The median normalized microarray data have
been used to compute the hierarchical clustering (Pearson correlation
distance function and average linkage method) and unsupervised princi-
pal component analysis (PCA), using the R software and the FactoMineR
package. The robustness of the hierarchical clustering was tested with the
support tree function of the MeV software (using the Pearson correlation
coefficient, average linkage, and 100 iterations): subgroups of gene ex-
pression data were permutated between samples (bootstrap), and the clas-
sification was repeated 100 times, generating a percentage of stability for
each branch. For the PCA, the eigenvalues correspond to the percentage of
the total variance of normalized signal data, and they are represented by a
given component (axis).
The lists of genes modulated by BTV infection in pDCs and cDCs from
the different lymphoid tissues (differentially expressed genes [DEG]) were
determined with methods that depended on the number of RNA samples
available from different sheep (biological replicates). For lymph node
cDCs and pDCs, hybridization was conducted with samples from 3 con-
trol and 3 BTV-infected sheep (6 days postinfection). In these cases, the
probe signals corresponding to genes significantly modulated during BTV
infection over control were analyzed by a linear model in the Limma R
package (25). The P values obtained have been corrected for multiple
testing using the Benjamini and Hochberg procedure (26). By conven-
tion, genes were considered differentially expressed in BTV infection (up-
or downmodulated) when their corresponding mean probe signal showed
a 2- or 0.5-fold change compared to the control condition, with an
adjusted P value of 0.05. For blood pDCs and for splenic cDCs, suffi-
cient quantities of RNA for hybridization on microarrays were only ob-
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tained from 2 controls and 2 infected sheep and from 3 control and 2
infected sheep, respectively, which did not allow reliable P values calcula-
tion. Genes were considered differentially expressed by BTV infection in
blood pDCs and splenic cDCs when their corresponding Agilent probe
signal showed a2- or0.5-fold change in the DCs from the 2 infected
sheep compared to all control sheep DC samples. The final DEG list was
prepared by keeping the genes from reliably annotated probes, removing
duplicates, and assigning the human official gene symbol to the probes for
subsequent meta-analysis.
For functional analysis, the DEG lists were submitted to Ingenuity
Pathway Analysis (IPA) software (Ingenuity Systems). Canonical pathway
analyses, Ingenuity downstream effects analyses (DEA), and Upstream
Regulator Prediction were conducted by the IPA software. The DEA ex-
amines genes in the DEG lists that are known to affect a given biological
function and compares their direction of change (up- or downmodula-
tion) to what is expected from the literature. When the direction of change
is consistent with the literature across the majority of genes, then the
function is predicted to be increased in the biological sample (z-score 
2), whereas if the direction of change is mostly anticorrelated with the
literature, then the function is predicted to be decreased in the biological
sample (z-score  2). If there is no clear pattern, then there is no pre-
diction either way. The Upstream Regulator Prediction analysis examines
how many known targets of each transcription regulator are present in the
DEG data set and also compares their direction of change to what is
expected from the literature in order to predict likely relevant transcrip-
tional regulators. If the observed direction of change is mostly consistent
with a particular activation state of the transcriptional regulator (“acti-
vated” or “inhibited”), then a prediction is made about that activation
state (z-score 2 for activation, z-score2 for inhibition). The white
paper regarding the algorithm used for DEA and Upstream Regulator is
available on the IPA website.
Real-time qPCR. For quantitation of gene expression in DCs, RNA
(200 ng) was reverse transcribed using random primers and the Mul-
tiscribe reverse transcriptase (Applied Biosystem). Real-time qPCR
was carried out using 5 ng cDNA with 300 nM primers in a final
reaction volume of 25 l of 1 SYBR green PCR Master Mix (Applied
Biosystem). The primers used to amplify ovine cDNA were designed
with the Primer Express software (v2.0) using publicly available
GenBank sequences. The primers used in this study are as follows:
GAPDH (glyceraldehyde-3-phosphate dehydrogenase) (forward, CA
CCATCTTCCAGGAGCGAG, reverse, CCAGCATCACCCCACTTG
AT); cyclophilin (forward, TGACTTCACACGCCATAATGG T, reverse,
CATCATCAAATTTCTCGCCATAGA); XCL1 (forward, TGAGCCAGA
GCAAGCCTACA, reverse, TCACTACCCAGTCAGGGTCACA-AAG
GAA CGC AAG AAC AGA ATG AA); XCR1 (forward, TGCCATCTTCC
ACAAGGTGTT, reverse, ACGGAGGCGAGGAACCA); TCF4 (forward,
TGGTCTGGCCTCAGGGTATG, reverse, GGCCCCAACCATGAGT
GA); FLT3 (forward, TGTTCACGCTGAATATAAGAAGGAA, reverse,
GGAGCAGGAAGCCTGACTTG); ID2 (forward, CAAGAAGGTGAGC
AAGATGGAA, reverse, CGCGATCTGCAAGTCCAA); SKT17 (forward,
GAAACACCCATGGCTGACTCA, reverse, GGCCCCTCTGACCTTG
AAA); CCR7 (forward, CCAGATGGTGGTAGGCTTCCT, reverse, GCG
GATGATGACAAGGTAGCA); EIF2AK2 (forward, AGGTTGGTCAAG
GATTTCACAGA, reverse, TCTGTGTTCGGCTTGAAAACTC); C-C
motif ligand 5 (CCL5) (forward, GTGGGTGCGAGAGTACATCAAC, re-
verse, GGCGCAAGTTCAGGTTCAAG); tryptophan-degrading enzyme
indoleamine 2,3 dioxygenase (IDO1) (forward, GCCTCCGAGGCCAC
AAG, reverse, CATACGCCATGGTGATGTATCC); C-X-C motif ligand
10 (CXCL10) (forward, GGTCCTTAGAAAAACTTGAACTGATTC, re-
verse, TCCTTTTCATTGTGGCAATAATCTC); IFN regulatory factor 8
(IRF8) (forward, GGAGTGTGGGCGCTCTGA, reverse, TCACCATCCC
CATGTAGTCATC); interleukin-1B (IL-1B) (forward, CGAACATGTCT
TCCGTGATG, reverse, TCTCTGTCCTGGAGTTTGCAT); IL-8 (for-
ward, TTCCAAGCTGGCTGTTGCTCTCTT, reverse, GCATTGGCATC
GAAGTTCTGTACTC); tumor necrosis factor (TNF) (forward, CAAGG
GCCAGGGTTCTTACC, reverse, GCCCACCCATGTCAAGTTCT);
IFNG (forward, TGATTCAAATTCCGGTGGATG, reverse, TTCATTGA
TGGCTTTGCGC). PCR cycling conditions were 95°C for 10 min, linked
to 40 cycles of 95°C for 15 s and 60°C for 1 min. Real-time qPCR data were
collected by the Mastercycler ep realplex-Eppendorf system, and 2	CT
calculations for the relative expression of the different genes (arbitrary
units) were performed with the Realplex software using GAPDH for nor-
malization in the pDC and cDC canonical gene expression experiment
and cyclophilin for normalization of the qPCR control experiment of the
microarray data. All qPCRs showed95% efficacy. Viral RNA detection
was performed using a commercial pan-BTV real time-RT-PCR (Adiavet
BTV Real-time A352; Adiagene, France) targeting segment 10 of BTV
(NS3), which is highly conserved among BTV serotypes, and the GAPDH
as an internal control.
Statistics for cell count data. Cell count data are presented as mean
values
 standard errors of the means (SEM). The statistical significance
between sets of cell count data was assessed with the two-tailed unpaired
Student t test.
Microarray data accession number. The data discussed in this article
have been deposited in NCBI’s Gene Expression Omnibus and are acces-
sible through GEO series accession number GSE48450.
RESULTS
BTV infection modifies the distribution of cDCs and pDCs in
lymphoid compartments. All the BTV8-infected sheep became
febrile 4 days after virus inoculation (D4) and developed moder-
ate disease by D5 to D17 (data not shown). Clinical signs were
characterized by fever, prostration, nasal discharge, conjunctivi-
tis, facial edema and congestion, hemorrhages, and ulceration of
the oral cavity. Hyperthermia (40.5°C) was detected in all in-
fected animals from D5 to D9 with a mean peak of 41.2°C at D6.
Neither clinical signs nor hyperthermia was observed in the non-
infected control group. BTV8 RNA copies were detected in all
infected sheep from D1 to D19 and reached between 4.2 and 6.6
log10 RNA copies per ml of blood with peaks of RNA viral detec-
tion between D5 and D9. In parallel, virus isolation was performed
and confirmed the infectivity of the blood samples. These viral and
clinical observations were similar to those described in other pub-
lished studies (5, 6, 20, 27, 28).
In lymph nodes, sheep cDCs had been previously identified as
CD1b cells (29). Sheep pDCs were previously extensively iden-
tified as CD45RBCD1bCD11cCD8TCR/BCD11b
cells in afferent skin lymph and blood (17, 30). We used a combi-
nation of markers to simultaneously label cDCs and pDCs among
lymph node LD cells (see Fig. S1A in the supplemental material).
The cDCs (CD1b cells) and pDCs (CD45RB cells) were isolated
from the FSChiCD8TCR/BCD11b cells. CD14 and B
cells were isolated as controls. In order to demonstrate the validity
of our cell isolation strategies, the expression of cDC and pDC
canonical genes was analyzed by qPCR in the sorted subsets. The
expression of the cDC canonical FLT3 (31) and XCR1 (32) genes
was selectively found in the CD1b cells, whereas the expression
of the pDC canonical TCF4 gene (33) was selectively found in the
CD45RB cells (see Fig. S1A in the supplemental material). Be-
cause the CD1b marker does not label cDCs in blood and spleen,
we identified cDCs as CD11c cells in these compartments (see
Fig. S1B in the supplemental material). In both blood and spleen,
theTCF4 gene was expressed mainly in the CD45RB population,
whereas the FLT3 and XCR1 genes were selectively expressed in
the CD11c cells and not in the CD11cCD45RB cells (see Fig.
S1B in the supplemental material). These double-negative cells
DC Transcriptome during BTV Infection
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strongly expressed XCL1 mRNA, suggesting that this population
included NK and/or activated CD8 T cells (32).
An analysis of the representation of pDCs and cDCs was con-
ducted in the draining lymph nodes, blood, and spleen during
BTV infection. Three time points were chosen: at D2 postinfec-
tion, when type I IFN was induced in the serum (17); at D6 postin-
fection, when the viremia peaked and symptoms appeared (this
study and others [5]); and at D10, when symptoms and virus
counts started to decrease (this study and others [5, 27]). As
shown in Fig. 1, the global leukocyte cellularity (top panel) was
higher in lymph nodes and spleen at D6 postinfection than in
controls. The cDC numbers per gram of local lymph node and
spleen were elevated in infected sheep at D6 compared to controls
(Fig. 1, middle panels; P  0.018 and P  0.039, respectively),
whereas they tended to be lower than in controls in blood at D6
postinfection. The reduction of cDC numbers in blood was tran-
sient and reached control values by D10. The effect of BTV infec-
tion on pDCs was less evident (Fig. 1, lower panels), and only
trends in pDC number modifications could be inferred. This was
in part due to the low number of sheep that we could handle under
the BSL3 conditions. The pDCs accumulated in the draining
lymph node at D10 (P 0.02), and a small increase was observed
in spleen at D10 (P 0.13). Conversely, pDC numbers tended to
be reduced in blood at D2 and D6 postinfection (P 0.17). Thus,
altogether, these analyses indicate that cDCs and pDCs accumu-
late in lymphoid organs and their numbers tend to transiently
decrease in blood during the first 10 days post-BTV infection.
BTV infection induces gene expression profiles in DCs that
depend on the pDC/cDC subtype and organ localization. In or-
der to gain insight into the role of cDCs and pDCs in the physio-
pathology of BTV infection, we chose to isolate cDCs and pDCs
from different lymphoid compartments at D6 following viral in-
oculation, i.e., at the onset of symptoms. Blood, spleen, and re-
gional draining lymph nodes are hypothesized to be important
sites in BT pathogenesis: cDCs were shown to strongly migrate
from skin to draining lymph node upon intradermal inoculation
of BTV and to be cell targets that disseminate the virus (8); fur-
thermore, the BTV load is important in the blood compartment
where cDCs and pDCs circulate (1, 34). From the lymph nodes of
our control and BTV-infected sheep, we isolated sufficient num-
bers of cDCs and pDCs (50,000 cells) to enable three indepen-
dent RNA hybridization replicates. We isolated sufficient RNA
quantities from 2 independent replicates of blood pDCs and
spleen cDCs. However, spleen pDCs and blood cDCs could not be
collected in sufficient numbers from infected sheep.
As a first exploratory analysis, the unsupervised hierarchical
FIG 1 Representation of cDCs and pDCs in the draining lymph nodes (A), blood (B), and spleen (C) during BTV infection. cDCs and pDCs were labeled from
LD cell preparations of lymph nodes, blood, and spleen as in Fig. S1 in the supplemental material. The percentage of DCs among other cells was used to calculate
their total number representation within the initial tissue and blood sample. Total numbers of leukocytes (top panels), cDCs (middle panels), and pDCs (bottom
panels) were reported per gram of tissue or per ml of blood. Three different sheep were used per time point (control and D2, D6, and D10 postinfection).
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clustering of normalized probe signals showed that the biological
duplicates and/or triplicates from different sheep all clustered to-
gether, indicating similarity of gene expression profiles between
replicates (Fig. 2). Furthermore, a bootstrap analysis using gene
data permutations with the MeV software (see Materials and
Methods) revealed a strong stability within the arms of the hier-
archical clustering (over 90%; data not shown), confirming the
similarity between experimental replicates. The hierarchical clus-
tering also reveals that the data group primarily according to the
tissue of origin and to the cDC and pDC types and secondly ac-
cording to the infected versus noninfected status (Fig. 2). A prin-
cipal component analysis (PCA) (Fig. 3) showed that the axes 1
and 3, both corresponding to the “tissue effect,” accounted for
39.46% and 8.97% of the data variance; the axis 2, corresponding
to the “DC subtype effect,” accounted for 17.85% of the data vari-
ance; and finally the axis 5, corresponding to the “infection effect,”
accounted for only 6.99% of the data variance. Thus, both the
hierarchical clustering and PCA suggest that the pDC/cDC types
and the lymphoid tissue of origin have more impact on the global
gene expression than the DC response to infection.
In order to analyze the effects of BTV infection on gene expres-
sion in DCs, the lists of the differentially expressed genes (DEG)
modulated upon BTV infection were established for the blood
pDCs (238 genes; see Table S1 in the supplemental material), the
lymph node pDCs (654 genes; see Table S2 in the supplemental
material), the lymph node cDCs (489 genes; see Table S3 in the
supplemental material), and the spleen cDCs (161 genes; see Table
S4 in the supplemental material), as described in Materials and
Methods. The modulation of gene expression determined in mi-
croarray analyses was confirmed using qPCR for several selected
genes in all DC subsets of different lymphoid compartments (see
Table S5 in the supplemental material), supporting the reliability
of the microarray data. BTV viral RNA was detected in cDCs and
pDCs from infected lymph nodes, suggesting that both cell types
were infected in vivo by BTV (see Fig. S2 in the supplemental
material). A comparison of these DEG lists was made in a Venn
diagram (Fig. 4) to identify genes modulated in common for the
different DC subsets. Only 3 downmodulated and 6 upregulated
genes were common to all the DEG lists. The majority of the up-
regulated (63%) and repressed (58%) genes were exclusive to
each DC subset of a given lymphoid compartment. Thus, our
global gene expression data analysis indicates that the cDC/pDC
type and the lymphoid organ location have an impact on the gene
expression program induced by BTV infection.
The functional gene expression profiles of DCs modulated
during BTV infection depend on the lymphoid compartments
and on the cDC/pDC types and suggest their distinct roles inBT
physiopathology. In order to get insight into the possible func-
tions of DCs in BT physiopathology, the DEG lists were submitted
to the integrative systems level analysis of the IPA software. The
predominant signaling pathways triggered in the DC subsets from
different compartments upon BTV infection were clearly distinct:
the dominant signaling pathways were the phospholipase C sig-
naling in spleen cDCs, the glucocorticoid receptor signaling in
lymph node cDCs, the NF-B and protein kinase R (PKR) signal-
ing in blood pDCs, and the vitamin D receptor/retinoid X recep-
tor (VDR/RXR) and peroxisome proliferator-activated receptor
(PPAR) signaling in lymph node pDCs (Fig. 5A; see Table S6 in the
supplemental material).
The DEA feature of IPA (see Materials and Methods) was used
to identify the biological functions that were expected to be in-
creased or decreased given the observed gene expression changes
upon BTV infection. Strikingly, many functions related to inflam-
mation and immunity were predicted to be activated in blood
pDCs upon BTV infection (Fig. 5B; see Table S7 in the supplemen-
tal material), and conversely these functions were not activated, or
even inhibited, in the lymph node pDCs and cDCs. Indeed, in
blood pDCs, chemotaxis (z-score  2.4), the inflammatory re-
sponse (z-score  2.2), and the permeability of vasculature (z-
score  2.2) were all predicted activated functions, in agreement
with the activation of the NF-B pathways (Fig. 5A). The in-
creased expression of inflammatory chemokine and cytokine
FIG 2 Hierarchical clustering of the microarray data from node, spleen, and blood cDCs and pDCs in control and BTV-infected sheep (D6). Hierarchical
clustering (Pearson-average method) was done on the normalized gene chips data. The data from three control sheep (C1, C2, and C3) and from 3 infected sheep
at day 6 (I1, I2, and I3) are reported. The samples grouped first according to their spleen (Spl), lymph node (LN), and blood (Bl) origin and to the type of DCs
(pDCs or cDCs) and secondly according to the BTV-infected or control status.
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genes (CCL2,CCL4,CXCL10, IL-8, IFNG,TNF; see Table S7 in the
supplemental material) and of other genes involved in increased
permeability of vasculature such as PTX3 (pentraxin 3) and
THSB1 (thrombospondin-1) suggests that blood pDCs could be
involved in the plasma leakages and the general inflammatory
state encountered in BTV infection. The upregulation of the CFB
(complement factor B) and F13A1 (coagulation factor XIII) genes
(see Table S1 in the supplemental material) suggests that pDCs
may also participate in blood coagulation disorders. The observed
upregulation of the gene expression of homing receptor CCR7
(see Table S1 in the supplemental material) can be related to the
accumulation of pDCs in lymph nodes during BTV infection (35).
Finally, blood pDCs showed activation of functions related to the
control of viral infection with inhibition of virus (z-score  2.5)
and killing of cells (z-score  2) that include upregulation of the
GZMB (granzyme B) gene (see Table S7 in the supplemental ma-
terial). Conversely, pDCs from regional node did not display at all
the proinflammatory gene expression profile expressed by blood
pDCs. In agreement with the dominant involvement of the anti-
inflammatory PPAR pathway (36) (Fig. 5A), node pDCs rather
expressed a trend to inhibition of inflammation (z-score 
1.778) and a significant prediction for reduction of chemotaxis
(z-score2.597) with downregulated expression of CCL4 and
upregulated expression of SOCS3 (suppressor of cytokine signal-
ing 3). The reduction of CCR7, CXCR4, and CXCR7 expression in
node pDCs is in accordance with the accumulation of pDCs in the
regional lymph node during BTV infection (see Table S2 in the
supplemental material). While expressing distinct genes upon
FIG 3 PCA on the microarray data from node, spleen, and blood cDCs and pDCs in control and BTV-infected sheep (D6). A PCA of the normalized gene chips
data from the spleen, lymph node, and blood pDCs (triangles) and cDCs (circles) of control (empty symbols) and infected sheep (filled symbols) generated 6 axes.
Axis 1 separated samples according to lymphoid organs, axis 2 according to DC types, axis 3 according to organs, and axis 5 according to BTV infection status.
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BTV infection (30% in common with pDCs [Fig. 4]), cDCs
from lymph nodes also displayed gene expression profiles predic-
tive of inhibition of inflammation and shock response (z-score
2 and 2.5, respectively [Fig. 5B]) as well as of cell death (z-
score 2.17) and lipid binding (z-score 2.4). The suppression
of inflammation unraveled by the DEA can be related to the in-
volvement of the glucocorticoid signaling pathway in node cDCs
(Fig. 5A), which has been associated in several instances to inhi-
bition of T cell activation by DCs (37). In the same trend toward
immune regulation or suppression, the expression of the IDO
(tryptophan-degrading enzyme indoleamine 2,3 dioxygenase)
gene was strongly increased (3.8-fold; see Table S3 in the supple-
mental material), and theADA (adenosine deaminase expression)
gene was also strongly suppressed in node cDCs (0.26-fold; see
Table S3 in the supplemental material). The activation of IDO has
been shown to be strongly involved in the induction of regulatory
FIG 4 Venn diagram comparison of the genes upregulated (A) and downmodulated (B) by BTV in lymph node pDCs, in lymph node cDCs, in blood pDCs, and
in spleen cDCs. Each of the four circles represents the list of the DG in the different DC subsets from the mentioned lymphoid organ (Spl, spleen; Bl, blood; LN,
lymph node). Numbers in the intersections between circles represent the numbers of common genes that are modulated in two, three, or four subset types.
FIG 5 Enrichment for canonical pathways and prediction of functions and of upstream regulators in blood and lymph node pDCs and in lymph node and spleen
cDCs upon BTV infection. The DEG lists in blood and node pDCs and in node and spleen cDCs were processed by the IPA software and the DEA tool. (A) Heat
map of the enriched canonical signaling pathways [Log (P values) in a red scale]. (B and C) Heat map of the generated statistically significant prediction values
for activated and inhibited functions (B) and upstream regulators (C), with z-scores of2 for activation and2 for inhibition. z-scores are reported in each
square.
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T cells by DCs (38), and the reduction of ADA was described to
lead to inhibition of T cell activation and to immunodeficiency
(39, 40). The reduction of the S1PR3 (sphingosine-1-phosphate
receptor 3) gene expression (0.43-fold) can be related to the accu-
mulation of cDCs within lymph nodes, as reduced expression of
this receptor has been previously demonstrated to play an impor-
tant role in cDC sequestration in lymph nodes (41).
An analysis of the upstream regulators provided by the IPA
software (Fig. 5C) indicates that many cytokines, eicosanoids, and
enzymes are predicted to be activators responsible for the gene
expression modulated by BTV in blood pDCs, whereas in many
instances their signaling is predicted to be inhibited in lymph node
pDCs, spleen cDCs, and lymph node cDCs. Interestingly, how-
ever, IFN is considered by IPA to be a positive regulator in all the
DCs irrespective of the DC types or of the lymphoid compartment
(Fig. 5C), although the IFN-induced genes were different between
the DC subsets (see Table S8 in the supplemental material).
Overall, our gene expression meta-analysis shows that the
pDC/cDC type and the lymphoid organ location have a strong
impact on the dominant signaling pathways and on the functional
gene expression profiles expressed by DCs upon BTV infection.
Notably, the transcriptomic profile of blood pDCs at the onset of
symptoms was associated with promotion of inflammation and
plasma leakages, whereas pDCs in the regional lymph node dis-
played an anti-inflammatory profile. In addition, cDCs in the re-
gional lymph node exhibited an anti-inflammatory and immuno-
regulatory gene expression profile. Thus, the transcriptomic
analysis suggests a role for DCs in BT pathogenesis that depends
on the DC subtypes and the organs in which these DCs reside at
the onset of symptoms.
DISCUSSION
We demonstrate that cDC and pDC subsets from different lym-
phoid compartments selectively activated or repressed different
sets of genes (from 36 to 240) upon BTV infections and possibly
contributed to viral pathogenesis. Our in vivo investigation in a
pertinent natural host allowed extraction of DC subsets from dif-
ferent lymphoid organs in sufficient quantities for microarray
studies, which would not have been technically possible using
nonhuman primate models. Even in our large-animal model, ex-
traction of enough DCs for microarray studies was not possible in
all instances, such as in the case of blood cDCs, due the paucity of
DC representation in our preserved samples.
As reported for several human viral infections such as human
immunodeficiency virus (HIV), hepatitis B and C viruses (HBV
and HCV), and dengue virus (42–45), the pDC and cDC numbers
appeared to decrease in blood during BTV infection. Given the
low numbers of sheep that we could technically handle during this
experimentation under BSL3 conditions, statistical significance
could not always be achieved; however, we were able to show
tendencies for decrease with cellular data that we obtained from 3
sheep per group. A strong decrease in pDC and cDC numbers in
blood has been described in HIV patients, and the restoration of
their numbers after primary HIV infection correlated with higher
CD4 T cell numbers and lower viral load (45). Similarly, in den-
gue virus infection, low numbers of circulating cDCs and pDCs in
humans and monkeys correlated with disease severity (42, 46). In
mice, a strong reduction of circulating pDCs was encountered in
herpes simplex virus, vesicular stomatitis virus, and murine cyto-
megalovirus (MCMV) infections and was related to pDC apopto-
sis induced by type I IFN (47), thus presumably avoiding excessive
systemic responses. In the case of BTV infection, blood pDCs did
not show gene signatures related to apoptosis but rather a trend to
increased cell survival (Fig. 5B; see Table S7 in the supplemental
material). In BTV infection, the accumulation of pDCs and cDCs
in lymph nodes may explain their reduction in blood. It should be
noted that their numbers were back to normal in blood at day 10.
As suggested for HIV (45), the recovery of a steady-state DC rep-
resentation in blood might be important in the resolution of BT
disease.
Recently, pDCs were shown to play a pivotal role in the sys-
temic inflammation induced by toll-like receptor 9 (TLR9) trig-
gering or by bacterial infections in vivo in mice (48). We show here
that a strong inflammatory gene profile was induced by BTV in
blood pDCs in vivo at day 6 postinfection, at the onset of symp-
toms, with expression of genes encoding cytokines such as CCL2,
CCL4, TNF, IL-8, and CXCL10 (see Table S7 in the supplemental
material). Notably, the in vitro stimulation of sheep pDCs with
replicative and UV-irradiated BTV8 triggered the upregulation of
TNF transcripts, but not that of IL-8 or CCL4 (S.R. and I.S.-C.,
data not shown), indicating that in vitro stimulation by BTV does
not faithfully mimic the viral stimulation of pDCs in vivo. Finally,
the permeability of vasculature was predicted to be an increased
function of pDCs during BTV infection, indicating that this cell
type could be involved in the hemodynamic disorders encoun-
tered in BTV infection. This finding is of importance, because it
allows us to hypothesize that blood pDCs are important cells in-
volved in the general symptoms of fever, inflammation, and
bleeding disorders in BT and possibly in other viral hemorrhagic
diseases. It should be pointed out that our experimental infection
in the Prealpes sheep breed led to a moderate severity of disease
expression, with facial edema and limited hemorrhagic lesions in
the oral cavity. A similar experiment using more sensitive breeds
such as Dorset Poll sheep would possibly unravel more-extensive
gene expression alterations in pDCs. Unfortunately, we could not
extract sufficient numbers of cDCs from blood. It can thus not be
known whether the proinflammatory profile found for blood
pDCs extends to the cDC type in blood.
We found that cDCs from spleen and lymph nodes and pDCs
from blood and lymph nodes expressed different functional gene
expression profiles, suggesting that the lymphoid tissue microen-
vironment shapes the DC transcriptomic program upon viral in-
fection. Under basal conditions, resident cDC (CD4 and CD8
types), but not pDCs, exhibit different genomic programs across
lymphoid organs (49). However, no studies to our knowledge pre-
viously evaluated the influence of the local milieu on the global
DC response during viral infection, although some suggested that
lymphoid organ location affects pDC response: during systemic
MCMV infection, pDCs produced type I IFN in a lymphoid or-
gan-specific manner (50); during lymphocytic choriomeningitis
virus (LCMV) infection, pDCs were activated for type I IFN pro-
duction in the pancreas (51), whereas they adopted a tolerogenic
profile in the pancreatic draining lymph node, under the control
of local NKT cells (52). However, it remains possible that the
difference of gene expression profile in lymph node and blood
pDCs is independent of the lymphoid organ environment but
reflects a difference of time lapse after stimulation by BTV: in that
scenario, pDCs stimulated in blood by BTV would undergo a pro-
inflammatory transcriptomic program that would be followed by
an anti-inflammatory transcriptomic program concomitant with
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entry into lymph nodes. The use of CCR7-deficient pDCs or of
anti-CCR7 MAb treatments to impede homing in lymph nodes
may allow determining whether the change of transcriptomic pro-
file in BTV-exposed pDCs is cell intrinsic or modified by the lym-
phoid environment; however, such investigations are not feasible
in sheep for the moment due to the lack of appropriate tools. The
lymph node environment may also partly explain the difference of
responses to BTV between isolated lymph cDCs and cDCs in the
node: indeed, we previously reported that BTV induced upregu-
lation of IL-12p40, IL-1, and IL-6 transcripts on isolated lymph
cDCs in vitro (8), whereas these transcripts were not upregulated
in vivo in lymph nodes in the present study. Finally, regardless of
the DC types and lymphoid tissue location, the only common
predicted activator among all the analyzed DCs appeared to be
IFN, which was previously shown by us to be detected in blood
from day 2 to day 6 in the same sheep study (published in refer-
ence 17). This finding suggests that the IFN response to BTV in-
fection is a major convergent response in DCs.
The transcriptomic analysis was conducted at day 6 postinfec-
tion, a time that corresponds to the peak of viremia and the be-
ginning of symptoms. However, it is possible that the major im-
pact of BTV infection on the gene expression reprogramming in
DCs would occur at an earlier time, as observed in the case of
MCMV infection in mice, where the maximum of DC activation
occurs at day 2 postinfection (53). Thus, the relatively low impact
of BTV infection on DC gene expression reprogramming ob-
served in our study may have been higher, or different, at an earlier
time postinfection.
The majority of genes activated and repressed in pDCs and
cDCs from lymph nodes during BTV infection were distinct and
corresponded to the enrichments of different canonical pathways
(Fig. 5A). A recent study of the gene expression program modu-
lated by MCMV infection also reported that hundreds of genes
were differentially modulated in splenic pDCs and cDCs and spe-
cific functional gene sets were induced by the infection in pDCs,
while they were unchanged or even repressed in cDC. This in-
cluded genes involved in mitosis/cell cycle and coexpressed with
Ccnb2 or induced by IL-15 (53). Together with these results, our
data indicate that viral infection modulates the gene expression
program in DCs depending on the DC type. The reason for the
distinct responses between the two DC types may be related to
differences in the basal genetic programs, in viral receptors, and in
dominant signaling pathways and could also be related to differ-
ences in viral infections. However, we found viral RNA both in
cDCs and in pDCs from lymph nodes at day 6, suggesting that
both cell types are infected by the virus, in agreement with our
previous in vivo and in vitro published results (see Fig. S2 in the
supplemental material and references 8 and 17). As our present
study relies on global RNA expression in the DCs, we cannot eval-
uate whether the gene expression program in DCs is directly re-
lated to viral infection of the same cells or is induced by sensing
without concomitant DC infection. Despite the modulation of
different sets of genes by BTV, both cDCs and pDCs from lymph
nodes displayed anti-inflammatory and antichemotactic signa-
tures that may contribute to avoiding the general cytokine storm
and possibly to controlling an excess of immune responses that
could lead to immunopathology. However, the extent and the
duration of the expression of regulatory or suppressive genes may
interfere with the establishment of protective immunity and sug-
gest that immunosuppression may be generated in some individ-
uals (54).
From these data, a BT physiopathology scenario involving DCs
can be speculated upon: together with the expression of their po-
tent viral defense, circulating pDCs participate in the triggering of
strong systemic inflammation, increased vasculature permeabil-
ity, and possibly bleeding disorders. Once in lymph nodes at day 6,
pDCs and cDCs express an anti-inflammatory profile, avoiding
excessive inflammation and immunopathology. It can be inferred
from this scenario that defects or excesses in the response of pDCs
and/or cDCs to BTV could impact the host response to this virus,
thus explaining the interindividual clinical sensitivity to BTV8
infection, which generally leads to a30% case fatality rate under
natural conditions (55). It suggests the hypothesis that genetic
resistance of ruminants to the disease might implicate DCs, al-
though the responses of other hematopoietic cells and endothelial
cells may also be involved. Extension of our findings to other
hemorrhagic viruses could lead the way to the developments of
treatments that modulate the responses of cDCs and pDCs, espe-
cially at the acute phase of the viral hemorrhagic disease manifes-
tation.
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